Christa Hegele-Hartung

Title: Inventor Spotlight: Christa Hegele-Hartung

Introduction

Christa Hegele-Hartung is a renowned inventor based in Mülheim an der Ruhr, Germany. With a commendable portfolio of three patents, she has made significant contributions to the field of pharmaceutical science. Her work focuses on innovative compounds that hold potential for treating serious diseases.

Latest Patents

Her latest patents revolve around dihydrooxadiazinone compounds, specifically addressing their chemical structures and applications. The invention provides dihydrooxadiazinone compounds of general formula (I) in which R, R, R, and R are specifically defined. These patents detail methods for preparing these compounds, as well as intermediate compounds useful for their synthesis. Furthermore, they encompass pharmaceutical compositions and combinations that employ these compounds to treat or prevent hyperproliferative diseases either as standalone agents or in conjunction with other active ingredients.

Career Highlights

Christa has held prestigious positions at Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft, where her expertise in drug development and innovation has flourished. Her contributions have been pivotal in advancing pharmaceutical sciences and addressing market needs through her inventive solutions.

Collaborations

Throughout her career, Christa has collaborated with notable individuals such as Manuel Ellermann and Stefan Nikolaus Gradl. These partnerships have enhanced her research endeavors, allowing her to push the boundaries of pharmaceutical innovation further.

Conclusion

In summary, Christa Hegele-Hartung stands out as an influential inventor in the pharmaceutical industry. With her impactful patents and collaborations, she continues to pave the way for innovative treatments aimed at improving health outcomes. Her work embodies the spirit of innovation that drives progress in medical science and enhances the lives of countless individuals.